AstraZeneca PLC (AZN) vs Salesforce, Inc. (CRM)
CRM leads on 9 of 17 compared metrics.
A side-by-side comparison of AstraZeneca PLC and Salesforce, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 15, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
Total return — AZN vs CRM
growth of $100 · last 22yAZN +279.6%CRM +3757.9%CRM compounded faster
Log scale — wide-divergence pair
AZN CRM
AZN vs CRM: by the numbers
- •AZN is the larger company ($277.22B vs $135.86B market cap).
- •CRM trades at the lower earnings multiple (19.22 vs 26.92 P/E).
- •CRM converts more revenue to profit (18.73% vs 17.19% net margin).
- •AZN grew revenue faster over the past five years (16.99% vs 13.89% CAGR).
- •AZN pays the higher dividend yield (1.79% vs 1.28%).
Which is better, AZN or CRM?
Metric tally: AZN 8 · CRM 9It depends on what you're optimizing for:
ValueCRM(lower P/E)
GrowthAZN(faster 5Y revenue CAGR)
IncomeAZN(higher dividend yield)
QualityAZN(higher ROIC)
Metrics side by side
Valuation
| Metric | AZN | CRM |
|---|---|---|
| P/E ratio | 26.92 | 19.22● |
| Forward P/E | 15.33 | 11.75● |
| P/S ratio | 4.62 | 3.37● |
| P/B ratio | 5.90 | 4.22● |
| PEG ratio | 0.14● | 1.24 |
| EV / EBITDA | 14.92 | 13.63● |
| FCF yield | 2.89% | 10.14%● |
Profitability
| Metric | AZN | CRM |
|---|---|---|
| Gross margin | 81.68%● | 77.64% |
| Operating margin | 23.69%● | 21.94% |
| Net margin | 17.19% | 18.73%● |
| ROE | 21.95% | 23.44%● |
| ROIC | 13.03%● | 8.76% |
Dividends
| Metric | AZN | CRM |
|---|---|---|
| Dividend yield | 1.79%● | 1.28% |
| Payout ratio | 48.48% | 27.11% |
Growth (annualized)
| Metric | AZN | CRM |
|---|---|---|
| Revenue CAGR (5Y) | 16.99%● | 13.89% |
| EPS CAGR (5Y) | 22.02%● | 11.87% |
| FCF CAGR (5Y) | 15.68% | 21.18%● |
| Total return CAGR (5Y) | 11.03%● | -6.82% |
Frequently asked
- Which is better, AZN or CRM?
- It depends on your goal. value: CRM (lower P/E); growth: AZN (faster 5Y revenue CAGR); income: AZN (higher dividend yield); quality: AZN (higher ROIC). Across all compared metrics, CRM leads 9 to 8.
- Is AZN or CRM cheaper?
- On trailing earnings, CRM is cheaper: AZN trades at a 26.92 P/E and CRM at 19.22.
- Which has grown faster, AZN or CRM?
- Over the past five years, AZN grew revenue faster — AZN at a 16.99% CAGR versus CRM at 13.89%.
- Does AZN or CRM pay a bigger dividend?
- AZN yields 1.79% and CRM yields 1.28% based on trailing dividends and the latest price.
- Is AZN or CRM more profitable?
- CRM runs the higher net margin — AZN at 17.19% versus CRM at 18.73%.
- Which has been the better investment, AZN or CRM?
- Over the past 10-year, AZN delivered the higher annualized total return — AZN at 15.77% versus CRM at 7.51%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AstraZeneca P/E ratioSalesforce P/E ratioAstraZeneca dividend yieldSalesforce dividend yieldAstraZeneca ROESalesforce ROEAstraZeneca operating marginSalesforce operating marginAstraZeneca revenue growthSalesforce revenue growthAstraZeneca free cash flowSalesforce free cash flow
AstraZeneca & Salesforce appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 15, 2026.